Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Hutchmed China Ltd ADR (HCM)

Hutchmed China Ltd ADR (HCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hutchmed China Ltd ADR 48TH FLOOR CHEUNG KONG CENTER 2 QUEEN`S ROAD CENTRAL HONG KONG K3 HKG

www.hutch-med.com Employees: 1,988 P: 852-2121-3888 F: 852-212-8177

Description:

HUTCHMED Limited is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. HUTCHMED Limited, formerly known as HUTCHMED (China) Limited, is based in HONG KONG.

Key Statistics

Overview:

Market Capitalization, $K 2,494,520
Enterprise Value, $K 2,290,280
Shares Outstanding, K 174,320
Annual Sales, $ 838,000 K
Annual Net Income, $ 100,780 K
Last Quarter Sales, $ 75,806 K
Last Quarter Net Income, $ -61,254 K
EBIT, $ 0 K
EBITDA, $ 26,590 K
60-Month Beta 0.78
% of Insider Shareholders 3.60%
% of Institutional Shareholders 8.82%
Float, K 168,044
% Float 96.40%
Short Volume Ratio 0.27

Growth:

1-Year Return -14.97%
3-Year Return -59.46%
5-Year Return -43.86%
5-Year Revenue Growth 291.39%
5-Year Earnings Growth 201.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/31/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

HCM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 292.20
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 12.03%
Debt/Equity 0.11
Price/Sales 3.04
Price/Cash Flow 23.36
Price/Book 3.39
Book Value/Share 4.32
Interest Coverage 77.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar